Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2141|162|2|229-239

ISSN: 0007-1048

Source: BRITISH JOURNAL OF HAEMATOLOGY, Vol.162, Iss.2, 2013-07, pp. : 229-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content